Literature DB >> 26755073

An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.

María Sánchez-Osuna1, Laura Martínez-Escardó1, Carla Granados-Colomina1, Fina Martínez-Soler1, Sònia Pascual-Guiral1, Victoria Iglesias-Guimarais1, Roser Velasco1, Gerard Plans1, Noemi Vidal1, Avelina Tortosa1, Carlos Barcia1, Jordi Bruna1, Victor J Yuste1.   

Abstract

BACKGROUND: Glioblastoma (GBM) or grade IV astrocytoma is one of the most devastating human cancers. The loss of DFF40/CAD, the key endonuclease that triggers oligonucleosomal DNA fragmentation during apoptosis, has been linked to genomic instability and cell survival after radiation. Despite the near inevitability of GBM tumor recurrence after treatment, the relationship between DFF40/CAD and GBM remains unexplored.
METHODS: We studied the apoptotic behavior of human GBM-derived cells after apoptotic insult. We analyzed caspase activation and the protein levels and subcellular localization of DFF40/CAD apoptotic endonuclease. DFF40/CAD was also evaluated in histological sections from astrocytic tumors and nontumoral human brain.
RESULTS: We showed that GBM cells undergo incomplete apoptosis without generating oligonucleosomal DNA degradation despite the correct activation of executioner caspases. The major defect of GBM cells relied on the improper accumulation of DFF40/CAD at the nucleoplasmic subcellular compartment. Supporting this finding, DFF40/CAD overexpression allowed GBM cells to display oligonucleosomal DNA degradation after apoptotic challenge. Moreover, the analysis of histological slices from astrocytic tumors showed that DFF40/CAD immunoreactivity in tumoral GFAP-positive cells was markedly reduced when compared with nontumoral samples.
CONCLUSIONS: Our data highlight the low expression levels of DFF40/CAD and the absence of DNA laddering as common molecular traits in GBM. These findings could be of major importance for understanding the malignant behavior of remaining tumor cells after radiochemotherapy.
© The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  apoptosis; caspase-dependent DNase (DFF40/CAD); caspase-dependent cell death; glioblastoma; oligonucleosomal DNA degradation

Mesh:

Substances:

Year:  2016        PMID: 26755073      PMCID: PMC4896542          DOI: 10.1093/neuonc/nov315

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  42 in total

Review 1.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

2.  A unique role of the DNA fragmentation factor in maintaining genomic stability.

Authors:  Bin Yan; Huili Wang; Yuanlin Peng; Ye Hu; He Wang; Xiuwu Zhang; Qi Chen; Joel S Bedford; Mark W Dewhirst; Chuan-Yuan Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.

Authors:  Alexander H Stegh; Hyunggee Kim; Robert M Bachoo; Kristin L Forloney; Jean Zhang; Harald Schulze; Kevin Park; Gregory J Hannon; Junying Yuan; David N Louis; Ronald A DePinho; Lynda Chin
Journal:  Genes Dev       Date:  2007-01-01       Impact factor: 11.361

4.  The absence of oligonucleosomal DNA fragmentation during apoptosis of IMR-5 neuroblastoma cells: disappearance of the caspase-activated DNase.

Authors:  V J Yuste; J R Bayascas; N Llecha; I Sánchez-López; J Boix; J X Comella
Journal:  J Biol Chem       Date:  2001-04-06       Impact factor: 5.157

5.  Caspase-activated DNase is necessary and sufficient for oligonucleosomal DNA breakdown, but not for chromatin disassembly during caspase-dependent apoptosis of LN-18 glioblastoma cells.

Authors:  María Sánchez-Osuna; Mercè Garcia-Belinchón; Victoria Iglesias-Guimarais; Estel Gil-Guiñón; Elisenda Casanelles; Victor J Yuste
Journal:  J Biol Chem       Date:  2014-05-17       Impact factor: 5.157

6.  Sequence elements in both subunits of the DNA fragmentation factor are essential for its nuclear transport.

Authors:  Sonja Neimanis; Werner Albig; Detlef Doenecke; Joerg Kahle
Journal:  J Biol Chem       Date:  2007-10-15       Impact factor: 5.157

7.  Cytogenetics of malignant gliomas: I. The autosomes with reference to rearrangements.

Authors:  B K Hecht; C Turc-Carel; M Chatel; P Grellier; J Gioanni; R Attias; P Gaudray; F Hecht
Journal:  Cancer Genet Cytogenet       Date:  1995-10-01

8.  Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme.

Authors:  Ruth Villalonga-Planells; Llorenç Coll-Mulet; Fina Martínez-Soler; Esther Castaño; Juan-Jose Acebes; Pepita Giménez-Bonafé; Joan Gil; Avelina Tortosa
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

9.  In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain.

Authors:  Carlos Barcia; Clare E Thomas; James F Curtin; Gwendalyn D King; Kolja Wawrowsky; Marianela Candolfi; Wei-Dong Xiong; Chunyan Liu; Kurt Kroeger; Olivier Boyer; Jerzy Kupiec-Weglinski; David Klatzmann; Maria G Castro; Pedro R Lowenstein
Journal:  J Exp Med       Date:  2006-08-21       Impact factor: 14.307

10.  Rethinking glioma treatment strategy.

Authors:  Tatsuya Ozawa; Eric C Holland
Journal:  Oncotarget       Date:  2014-10-30
View more
  8 in total

Review 1.  Autonomic nervous system and cancer.

Authors:  Marta Simó; Xavier Navarro; Victor J Yuste; Jordi Bruna
Journal:  Clin Auton Res       Date:  2018-03-28       Impact factor: 4.435

2.  DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells.

Authors:  Raheleh Amrollahi-Nia; Vajihe Akbari; Fatemeh Shafiee
Journal:  Biotechnol Lett       Date:  2021-09-05       Impact factor: 2.461

3.  Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells.

Authors:  Merve Kulbay; Bruno Johnson; Guillaume Ricaud; Marie-Noëlle Séguin-Grignon; Jacques Bernier
Journal:  Mol Cell Biochem       Date:  2022-04-22       Impact factor: 3.842

4.  PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism.

Authors:  Santiago Serrano-Saenz; Carmen Palacios; Daniel Delgado-Bellido; Laura López-Jiménez; Angel Garcia-Diaz; Yolanda Soto-Serrano; J Ignacio Casal; Rubén A Bartolomé; José Luis Fernández-Luna; Abelardo López-Rivas; F Javier Oliver
Journal:  Cell Death Dis       Date:  2019-01-18       Impact factor: 8.469

5.  Two Simple Methods for Optimizing the Production of "Difficult-to-Express" GnRH-DFF40 Chimeric Protein.

Authors:  Mahdi Barazesh; Zohreh Mostafavipour; Soudabeh Kavousipour; Shiva Mohammadi; Pooneh Mokarram
Journal:  Adv Pharm Bull       Date:  2019-08-01

Review 6.  The role of the DFF40/CAD endonuclease in genomic stability.

Authors:  Merve Kulbay; Nathan Bernier-Parker; Jacques Bernier
Journal:  Apoptosis       Date:  2021-01-02       Impact factor: 4.677

7.  DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.

Authors:  Tomasz Banas; Kazimierz Pitynski; Krzysztof Okon; Aleksandra Czerw
Journal:  Onco Targets Ther       Date:  2017-09-14       Impact factor: 4.147

8.  Immunoexpression of DNA fragmentation factor 40, DNA fragmentation factor 45, and B-cell lymphoma 2 protein in normal human endometrium and uterine myometrium depends on menstrual cycle phase and menopausal status.

Authors:  Tomasz Banas; Kazimierz Pitynski; Krzysztof Okon; Marcin Mikos; Aleksandra I Czerw; Andrzej Deptała; Artur Ludwin
Journal:  Arch Med Sci       Date:  2017-07-31       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.